12 results found
The early years, particularly the first 1,000 days, are a critical period in a child’s development, with lifelong impacts. Evidence shows that one of the most effective strategies for economic growth is investing in the developmental growth of at-risk young children. However, early childhood development (ECD) programmes are severely challenged by the sheer scale of need in the face of early childhood care and education losses due to COVID-19 me
With commitment, collaboration, and a comprehensive approach, the G20 has the capacity to guide us toward a future where mental health occupies a cent
By fostering evidence-based youth policies, societies can work towards implementing the SDGs at all levels, thus benefiting the youth and enhancing ov
India wants Sri Lanka to find out the ‘real purpose’ of the ship’s visit, implying that it was open to evidence-based arguments.
India's upcoming presidency could be an opportunity to make global health governance more democratic and evidence-based.
In May 2016, the Health Secretaries of the States and Union Territories of India gathered in the capital and issued “The Delhi Commitment on Sustainable Development Goals for Health”. Among others, the document acknowledged the need to invest in health data collection, analysis and research so that these can properly inform government policies and strategies necessary to address the various challenges facing India’s healthcare. Such commitm
The February 2017 order by the National Pharmaceutical Pricing Authority (NPPA) for fixing the price ceiling for cardiac stents—a device that normalises blood supply to the heart—brings to fore the old debate on the influence of business in healthcare in India. In view of the increasing number of catheterisation laboratories in the country, and the rise in the use of cardiac stents, this article discusses, inter alia: (a) the role of price
The COVID-19 pandemic is taking an enormous toll on health systems across the world. A growing concern is that efforts to manage the pandemic are undermining care for serious non-Covid illnesses such as cancer. In the UK and US, for example, it is estimated that delays in cancer diagnosis and treatment due to COVID-19 will lead to excess cancer deaths in the range of tens of thousands within a year. In India, where health systems are weak, it is
In August 2019, the Reserve Bank of India (RBI) released its final guidelines for a regulatory sandbox for fintech firms.[1] Technology innovations are disrupting the traditional financial sector, and the RBI’s regulatory sandbox exercise is an attempt to be more agile and absorb some of this disruption. ‘Sandboxes’ give regulators a chance to work with fintech innovators, mitigate potential risks and develop evidence-based policy, while fi
